Physician profile
Matthew Ostroff
NPI 1982131405
$27,442.40
in general payments reported to CMS, 2019-2025
14 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $540 · 2022: $749 · 2023: $7,775 · 2024: $7,202 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,933 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,250 · Travel and Lodging: $4,937 · Food and Beverage: $2,121 · Honoraria: $1,913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,932.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,250.00 |
| Travel and Lodging | $4,936.71 |
| Food and Beverage | $2,121.31 |
| Honoraria | $1,912.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $8,799.38 | 2021-2023 | 3m Tegaderm, Tegaderm, Promogran Prisma |
| Teleflex LLC | $7,983.74 | 2024-2025 | Arrow |
| Becton, Dickinson and Company | $3,506.68 | 2025 | Alaris, Smartsite |
| Access Vascular INC | $2,696.49 | 2024-2025 | Vannas Capsulotomy Scissors, Hydropicc Dual Lumen, Hydromid Maximal Barrier Kit |
| Ecs Opco 1 LLC | $2,673.86 | 2024-2025 | Piccolo Medical, Bioflo, Cook Spectrum |
| Solventum Corporation | $992.50 | 2024-2025 | Tegaderm |
| B. Braun Medical INC. | $223.29 | 2025 | Introcan Safety |
| Angiodynamics, INC. | $151.38 | 2022-2024 | Bioflo |
| Arrow International, INC. | $131.32 | 2024 | Arrow |
| Mozarc Medical US LLC | $97.11 | 2023 | Chameleon |
| Bard Access Systems, INC. | $59.79 | 2022 | |
| Axogen | $52.70 | 2025 | |
| Novartis Pharmaceuticals Corporation | $48.16 | 2024-2025 | |
| Prytime Medical Devices, INC. | $26.00 | 2023 | Er-Reboa Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ostroff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.